| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/15/2002 | US20020111345 Use of taurolidine to treat tumors |
| 08/15/2002 | US20020111336 Topical composition |
| 08/15/2002 | US20020111326 Using quaternary ammonium compound |
| 08/15/2002 | US20020110780 Oral therapeutic delivery appliance |
| 08/15/2002 | US20020110635 Impermeable cup or coating layer is adhered to an uncured suture tab and covered with permeable polymer (polyvinyl acetate); for use in treatment of retinitits and glaucoma |
| 08/15/2002 | US20020110633 Process for producing a powder containing crystalline particles of maltitol |
| 08/15/2002 | US20020110601 Antineoplastic platinum therapeutic method and composition |
| 08/15/2002 | US20020110599 Dissolving or dispersing active compounds in aqueous or colloidal dispersion of a proteinaceous protecting colloid, flocculating with active compound out of dispersion separating off flocculated solid; forming dry powder |
| 08/15/2002 | US20020110598 Growth stimulant compositions |
| 08/15/2002 | US20020110597 Redispersibility upon administration to human or animal |
| 08/15/2002 | US20020110596 Time-release agents |
| 08/15/2002 | US20020110595 Slow release pharmaceutical compositions |
| 08/15/2002 | US20020110594 Antibiotic/benzoyl peroxide dispenser |
| 08/15/2002 | US20020110593 Therapy of disease by the release of drugs in the gastrointestinal tract in a location- and time-dependent manner |
| 08/15/2002 | US20020110592 Sustained release drug delivery devices with multiple agents |
| 08/15/2002 | US20020110591 Sustained release drug delivery devices |
| 08/15/2002 | US20020110590 Pharmaceutical formulation containing DEMO for the treatment of cancer |
| 08/15/2002 | US20020110588 Liposome compositions and methods for the treatment of atherosclerosis |
| 08/15/2002 | US20020110587 Liposomal compositions, and methods of using liposomal compositions to treat dislipidemias |
| 08/15/2002 | US20020110586 Liposomal antineoplastic drugs and uses thereof |
| 08/15/2002 | US20020110585 Enhanced ability to camouflage wrinkles and swelling, greater permeability of the backing to water vapor and oxygen, flexibility and conformability, and thus, enhanced comfort |
| 08/15/2002 | US20020110583 Hair cap with conditioner |
| 08/15/2002 | US20020110581 Providing a product that includes a consumable center and a coating that substantially surrounds consumable center, coating containing a medicament; placing product in mouth of individual and causing the medicament to be released |
| 08/15/2002 | US20020110578 Sublingual buccal effervescent |
| 08/15/2002 | US20020110577 Method and non-gelling composition for inhibiting post-surgical adhesions |
| 08/15/2002 | US20020110568 Effective in eliciting the production of antibodies that recognize epitopes of native proteins |
| 08/15/2002 | US20020110561 For use in therapy, sustained release of drugs |
| 08/15/2002 | US20020110552 Stabilized liquid preparation of the protease which activates blood coagulation factor VII, or of its proenzyme |
| 08/15/2002 | US20020110539 Modulated release particles for lung delivery |
| 08/15/2002 | US20020110538 Methods and products for tumor immunotherapy using cytokines |
| 08/15/2002 | US20020110533 Liquid phase is added to a tank which is being connected to a homogenizer of rotor/stator type; homogenizer is started and subsequently second phase, which is insoluble in added phase and is to be homogenized, is supplied in liquid form |
| 08/15/2002 | US20020110530 For reducing the presence of microorganism; for use in mouthrinse, soaps, dentrifice, deodorant formulations |
| 08/15/2002 | US20020110529 Inhalable powder containing tiotropium |
| 08/15/2002 | US20020110528 Stability, aerosols, drug delivery; therapy |
| 08/15/2002 | US20020110527 Stability, aerosols, drug delivery; therapy |
| 08/15/2002 | US20020110526 Modulated release particles for lung delivery |
| 08/15/2002 | US20020110525 Modulated release particles for lung delivery |
| 08/15/2002 | US20020110524 Method for stabilizing biomolecules in liquid formulations |
| 08/15/2002 | US20020109025 Generating fine medicament powders suitable for inhalation using a fluid energy milling with milling fluid such as air or nitrogen at a controlled relative humidity 30-50%; triamcinolone acetonide or salbutamol sulfate |
| 08/15/2002 | US20020108533 A hardenable propylene glycol alginate (PGA) film-former and a surfactant in an aqueous solution of low viscosity; prompt release for drug and veterinary solid dosage forms, candy, seeds, animal feed, fertilizers, pesticides and foods |
| 08/15/2002 | CA2796884A1 Improved controlled release oral dosage form |
| 08/15/2002 | CA2685214A1 Improved controlled release oral dosage form |
| 08/15/2002 | CA2473847A1 Oral drug delivery system |
| 08/15/2002 | CA2438208A1 Devices and methods for management of bone density |
| 08/15/2002 | CA2437630A1 Method for producing a floating tablet containing an active principle |
| 08/15/2002 | CA2437375A1 Methods and compositions for reducing the taste of pharmaceutically active agents |
| 08/15/2002 | CA2437372A1 Oral itraconazole formulations and methods of making the same |
| 08/15/2002 | CA2437272A1 Modified erythropoietin (epo) with reduced immunogenicity |
| 08/15/2002 | CA2437270A1 Modified keratinocyte growth factor (kgf) with reduced immunogenicity |
| 08/15/2002 | CA2437265A1 Modified leptin with reduced immunogenicity |
| 08/15/2002 | CA2437263A1 Modified human brain-derived neutrophic factor (bdnf) with reduced immunogenicity |
| 08/15/2002 | CA2437214A1 Modified interleukin-1 receptor antagonist (il-1ra) with reduced immunogenicity |
| 08/15/2002 | CA2437087A1 Methods for the administration of amifostine and related compounds |
| 08/15/2002 | CA2436374A1 Water-soluble compositions of bioactive lipophilic compounds |
| 08/15/2002 | CA2435982A1 Medicaments |
| 08/15/2002 | CA2435546A1 Rapid-onset medicament for the treatment of sexual dysfunction |
| 08/15/2002 | CA2434566A1 Parenteral formulation containing epothilone analogs |
| 08/15/2002 | CA2434079A1 Cyanoacrylate compositions for prophylactic or therapeutic treatment of diseases manifesting themselves in and/or damaging cutaneous tissue |
| 08/14/2002 | EP1231277A2 Biocompatible implant for in vivo formation of a neo-organ |
| 08/14/2002 | EP1230934A1 Polyion complex micelles of core/shell structure |
| 08/14/2002 | EP1230930A2 Bmp-9 compositions |
| 08/14/2002 | EP1230917A1 Invasomes for the therapy of illnesses, their manufacture and use |
| 08/14/2002 | EP1230916A2 Aqueous medicament preparations for the production of propellant gas-free aerosols |
| 08/14/2002 | EP1230338A1 Continuous-flow method for preparing microparticles |
| 08/14/2002 | EP1230267A2 Membrane translocating peptide drug delivery system |
| 08/14/2002 | EP1230250A2 Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors |
| 08/14/2002 | EP1230237A1 Magnesium omeprazole |
| 08/14/2002 | EP1230030A2 Article comprising a diffuser with flow control features |
| 08/14/2002 | EP1230003A2 A method of producing organic emulsifiers and organic surfactants, products produced by said method, and the use of such products |
| 08/14/2002 | EP1229954A1 Method of treating cardio pulmonary diseases with no group compounds |
| 08/14/2002 | EP1229942A1 Method and formula for tumor remission and suppression of cancer |
| 08/14/2002 | EP1229932A2 Induction of mucosal immunity by vaccination via the skin route |
| 08/14/2002 | EP1229930A1 Compositions and methods for treatment of allergic disorders |
| 08/14/2002 | EP1229923A1 Inhibition of pathogens by bacillus coagulans strains |
| 08/14/2002 | EP1229922A2 Aplidine treatment of cancers |
| 08/14/2002 | EP1229920A1 Therapy with 2-5a and interferon |
| 08/14/2002 | EP1229918A2 Pharmaceutical composition comprising a combination of metformin and glibenclamide |
| 08/14/2002 | EP1229917A1 Pharmaceutical compositions and preparations for treatment of metabolic bone disease |
| 08/14/2002 | EP1229916A2 Combination chemotherapy |
| 08/14/2002 | EP1229913A1 Substituted 1-benzazepines and derivatives thereof |
| 08/14/2002 | EP1229909A2 Transdermal delivery of lasofoxifene |
| 08/14/2002 | EP1229905A2 Transdermal drug delivery devices comprising (r)-(z)-1- azabicyclo[2.2.1]heptan-3-one, o-[3(3-methoxyphenyl)-2-propynyl]oxime |
| 08/14/2002 | EP1229904A1 Method for producing a moulded body containing starch |
| 08/14/2002 | EP1229903A1 A method for chemoprevention of prostate cancer |
| 08/14/2002 | EP1229901A1 Microfabricated devices for the delivery of molecules into a carrier fluid |
| 08/14/2002 | EP1229900A1 Sustained-release drug formulations for implantation |
| 08/14/2002 | EP1229897A2 Personal care articles comprising cationic polymer coacervate compositions |
| 08/14/2002 | EP1229867A2 Ophthalmologic implant |
| 08/14/2002 | EP1047396B1 Lipoprotein creams |
| 08/14/2002 | EP1014993B1 New use for budesonide and formoterol |
| 08/14/2002 | EP0977582B1 Pharmaceutical combined preparations containing erythropoietin and iron preparations |
| 08/14/2002 | EP0975532B1 Multi-compartment rehydrating container |
| 08/14/2002 | EP0969806B1 Keratotic plug remover |
| 08/14/2002 | EP0952825B1 Patch carrying a particulate material and a magnet |
| 08/14/2002 | EP0944675B1 Stable, aqueous dispersions and stable, water-dispersible dry xanthophyll powder, their production and use |
| 08/14/2002 | EP0907364B1 Sustained release pharmaceutical compositions comprising a dibenzothiazepine derivative |
| 08/14/2002 | EP0906262B1 Colchicine-skeleton compounds, their use as medicaments and compositions containing them |
| 08/14/2002 | EP0861068B1 Method and device for producing a parenteral medicament |
| 08/14/2002 | EP0855903B1 Cosmetic composition for the treatment of keratinous materials comprising at least a grafted silicone polymer and at least an aqueous dispersion of insoluble particles of non ionic or cationic polymer |
| 08/14/2002 | EP0817614B1 Stable protein-phospholipid compositions and method of preparation |